Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Lymphoma

  Free Subscription


15.07.2024

1 Am J Hematol
1 Am J Surg Pathol
2 Blood
3 Br J Haematol
3 Haematologica
1 Hum Pathol
1 Int J Cancer
3 Leuk Lymphoma
1 Neurology
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. VEILLEUX O, Socola F, Arai S, Frank MJ, et al
    Management of post-autologous transplant relapse in patients with T-cell lymphomas.
    Am J Hematol. 2024;99:1485-1491.
    PubMed         Abstract available


    Am J Surg Pathol

  2. WANG SH, Chiang PM, Su YY, Yu YT, et al
    Cytoplasmic Lipid Droplets Predict Worse Prognosis in Diffuse Large B-Cell Lymphoma: Next-Generation Sequencing Deciphering Lipogenic Genes.
    Am J Surg Pathol. 2024 Jul 9. doi: 10.1097/PAS.0000000000002280.
    PubMed         Abstract available


    Blood

  3. PICCALUGA PP
    SOX11 in EBV-negative Burkitt lymphoma.
    Blood. 2024;144:128-129.
    PubMed        

  4. FALINI B, Lazzi S
    Mantle cell lymphoma with IRTA1+ reactive expansion of the marginal zone.
    Blood. 2024;144:237.
    PubMed        


    Br J Haematol

  5. CARLO-STELLA C
    Relapse after glofitamab, a novel unmet medical need with high rates of CD20 loss.
    Br J Haematol. 2024;205:17-19.
    PubMed         Abstract available

  6. GRIGG S, Minson A, Prins E, Dickinson MJ, et al
    Relapse after glofitamab has a poor prognosis and rates of CD20 loss are high.
    Br J Haematol. 2024;205:122-126.
    PubMed         Abstract available

  7. CIVALLERO M, Schroers-Martin JG, Horwitz S, Manni M, et al
    Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project.
    Br J Haematol. 2024;205:166-174.
    PubMed         Abstract available


    Haematologica

  8. DOURTHE ME, Auperin A, Rigaud C, Barbati M, et al
    Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with FAB/LMB-based chemotherapy regimen with rituximab.
    Haematologica. 2024 Jul 11. doi: 10.3324/haematol.2024.285403.
    PubMed         Abstract available

  9. SERNA A, Navarro V, Iacoboni G, Lopez L, et al
    Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes.
    Haematologica. 2024 Jul 11. doi: 10.3324/haematol.2024.285219.
    PubMed         Abstract available

  10. WANG L
    Have we truly uncovered the key to primary vitreoretinal lymphoma's pathway to the central nervous system?
    Haematologica. 2024 Jul 11. doi: 10.3324/haematol.2024.286056.
    PubMed         Abstract available


    Hum Pathol

  11. CHEN BJ, Hsieh SM, Hsieh TH, Jhuang JY, et al
    DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1- immunophenotype.
    Hum Pathol. 2024;150:58-66.
    PubMed         Abstract available


    Int J Cancer

  12. SARATHKUMARA YD, Xian RR, Liu Z, Yu KJ, et al
    A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations.
    Int J Cancer. 2024 Jul 12. doi: 10.1002/ijc.35072.
    PubMed         Abstract available


    Leuk Lymphoma

  13. VIJENTHIRA A, Li X, Crump M, Hay AE, et al
    Development and testing of a lymphoma clinical trial-specific frailty index: a secondary analysis of the NCIC-CTG LY.12 clinical trial.
    Leuk Lymphoma. 2024 Jul 9:1-8. doi: 10.1080/10428194.2024.2370437.
    PubMed         Abstract available

  14. J WU J, Wade SW, Itani T, Castaigne JG, et al
    Unmet needs in relapsed/refractory mantle cell lymphoma (r/r MCL) post-covalent Bruton tyrosine kinase inhibitor (BTKi): a systematic literature review and meta-analysis.
    Leuk Lymphoma. 2024 Jul 8:1-14. doi: 10.1080/10428194.2024.2369653.
    PubMed         Abstract available

  15. ZHANG JR, Wu SY, Jain P, Ok CY, et al
    Characteristics, treatment, and outcomes of mantle cell lymphoma with cutaneous involvement: a decade-long study at MD Anderson cancer center.
    Leuk Lymphoma. 2024 Jul 7:1-4. doi: 10.1080/10428194.2024.2374457.
    PubMed        


    Neurology

  16. AZZIMONTI M, Esposito F, Poliani PL, Gagliardi F, et al
    Teaching NeuroImage: Spontaneously Resolving Ring-Enhancing Lesions Due to Immunodeficiency-Associated CNS Lymphoma: A Case of "Vanishing Lymphoma".
    Neurology. 2024;103:e209644.
    PubMed        


    PLoS One

  17. OLAND CB, Ranch LS, Skaaby T, Delvin T, et al
    Reverse causation bias: A simulation study comparing first- and second-line treatments with an overlap of symptoms between treatment indication and studied outcome.
    PLoS One. 2024;19:e0304145.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.